Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 9/20 | 0.44 |
| ▸ | AGTR2 | P50052 | 8/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9528328 | 0.95 | AGTR1 (0.51) | AGTR1AGTR2 | |
| SCHEMBL9529063 | 0.94 | AGTR1 (0.49) | AGTR1AGTR2 | |
| SCHEMBL9532420 | 0.93 | AGTR1 (0.41) | AGTR1AGTR2 | |
| SCHEMBL9527276 | 0.93 | AGTR1 (0.41) | AGTR1AGTR2 | |
| SCHEMBL9700836 | 0.93 | AGTR1 (0.40) | AGTR1AGTR2PDE4APDE4BPDE4C | |
| SCHEMBL9529437 | 0.92 | AGTR1 (0.39) | AGTR1AGTR2 | |
| SCHEMBL9527294 | 0.91 | AGTR1 (0.40) | AGTR1AGTR2 | |
| SCHEMBL9527368 | 0.90 | AGTR1 (0.39) | AGTR1AGTR2 | |
| SCHEMBL9528753 | 0.89 | AGTR1 (0.38) | AGTR1AGTR2 | |
| SCHEMBL9527268 | 0.88 | AGTR1 (0.37) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| US-5098920-A | Hypotensive agents and treatment of congestive heart failure | G. D. SEARLE & CO. (US) | 1992-03-24 | — | — | US | disclosed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | disclosed |